Understanding The Role of LELP1 in Cell Signaling and Disease

Target Name: LELP1

NCBI ID: G149018

LELP1

Understanding The Role of LELP1 in Cell Signaling and Disease

LELP1 (Leucine-Encoded Leucine-Practitioner) is a protein that is expressed in various tissues of the human body, including the brain, heart, and muscle. It is made up of 21 different amino acids, and its function is not yet fully understood. However, research has suggested that LELP1 may have a role in the development and progression of various diseases, including cancer.

One of the key functions of LELP1 is its role in cell signaling. LELP1 has been shown to play a role in the regulation of cell proliferation and differentiation, as well as in the regulation of cellular signaling pathways that are involved in the development of cancer.

In addition to its role in cell signaling, LELP1 has also been shown to play a role in the regulation of inflammation. Studies have suggested that LELP1 may be involved in the regulation of the immune response, and that it may play a role in the development of certain inflammatory diseases.

Another potential function of LELP1 is its role in the regulation of pain. LELP1 has been shown to play a role in the regulation of pain sensitivity, and that it may be involved in the development of certain pain conditions.

Overall, while more research is needed to fully understand the role of LELP1 in the human body, it is clear that it is a protein that is involved in a wide range of physiological processes that are important for the health and well-being of the body.

Protein Name: Late Cornified Envelope Like Proline Rich 1

The "LELP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LELP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets